Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The in vitro diagnostics group bioMérieux has revised its annual targets downward following a first quarter impacted by weak respiratory epidemiology …
bioMérieux's stock closed the Thursday session on April 9 at €89.60, down 3.29% from the previous day. This decline highlights a marked downward traje…
The in vitro diagnostics specialist's stock fell close to 2% this Tuesday, amidst a generally declining Parisian market. This new session of decline a…
bioMérieux has announced the acquisition of the CE mark under the IVDR directive for two diagnostic tests for respiratory and pharyngeal infections. T…
BioMérieux's stock experienced a significant decline of 2.75% this Thursday, March 5, closing at 95.40 euros after ending at 98.10 euros the previous …
Alphavalue ajuste sa valorisation sur le titre Biomerieux ce lundi 2 mars 2026.
In vitro diagnostics group bioMérieux recorded a revenue of 4,070 million euros in 2025, marking an organic growth of 6.2%. The contributory operating…
French company bioMérieux announced on February 18, 2026, the launch of SMARTBIOME, a solution aimed at the agri-food industry to better understand an…
Oddo BHF établit une recommandation surperformer sur Biomerieux et fixe un objectif de cours à 110 €.
The stock of bioMérieux, a French specialist in in vitro diagnostics, has had a tough week. The share price closed on Friday at 97.80 euros, marking a…
